News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alltracel Pharmaceuticals Plc Announces Nanopeutics Agreement


11/12/2007 10:10:04 AM

Alltracel Pharmaceuticals Plc., ("Alltracel" or "the Company"), (AIM:AP.L), the healthcare innovation group focused on oral care, wound care, cardiovascular health and dermal health markets, today announces that its Nanopeutics subsidiary has signed a collaborative technology development agreement with ConvaTec, a world-leading manufacturer of ostomy and wound care products with a 25-year heritage of caring for patients.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES